Even with the (dirt cheap) saline and needle cost added, you are still way ahead
Compared to short-acting exenatide, long-acting ones such as dulaglutide, liraglutide, and exenatide once-weekly reduced hemoglobin A1c (HbA1c) by 0.51%, 0.45%, and 0.38% respectively [62]
Matek D et al
13 BirchmeierC.BirchmeierW.GherardiE.Vande WoudeG
The authors compare multiple senolytic strategies including FOXO4-DRI, dasatinib plus quercetin, navitoclax, and fisetin, evaluating mechanisms of action, selectivity profiles, and safety considerations for each approach
Theyre even more effective together